Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers
Yali Zhong(Oslo University Hospital), Zhenhe Suo(Oslo University Hospital), Yaqing Li(Shenyang Pharmaceutical University), Bin Hao(Second Affiliated Hospital of Zhengzhou University), Yasai Ji(First Affiliated Hospital of Zhengzhou University), Long Yuan(Wuhan Children's Hospital), Mingzhi Zhang(Chinese Academy of Sciences), Jian Liu(Edinburgh College), Xiaoli Li(A*STAR Graduate Academy), Mariusz Adam Goscinski(Oslo University Hospital), Jianguo Wen(Argonne National Laboratory), Xiaoran Li(Shanghai Jiao Tong University), Huixiang Li(Zhengzhou University), Dandan Yu(Union Hospital), Zhenyu Ji(Bengbu Medical College), Jahn M. Nesland(Oslo University Hospital), Yuan Yuan(Nanjing University of Chinese Medicine), Dandan Fan(Zhejiang Lab)
Cited by 36
Related Papers
5-Aminolevulinic acid-based photodynamic therapy
|Cancer|1997|976
Molecular cloning and functional expression of a mu opioid receptor from rat brain
|Regulatory Peptides|1994|810
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
|Journal of Hematology & Oncology|2022|687
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296